Vaxcyte target price raised to $122 from $110
PCVX•Needham raised its target price for Vaxcyte to $122 from $110.
Related News
JPMorgan raises RXO to neutral from underweight and target price to $30 from $22
RXO•
Symbotic director Charles Kane disposes of $85,895 of common shares
SYM•
Sprouts Farmers Market: JPMorgan cuts target price to $90 from $103
SFM•
Japan bonds pare losses after strong auction, but fiscal worries weigh
TLT•
Gulf oil flows rise to average 81% of pre-war rate in September, data shows
USO•